ES2138366T3 - Indol carbamatos como antagonistas de leucotrienos. - Google Patents

Indol carbamatos como antagonistas de leucotrienos.

Info

Publication number
ES2138366T3
ES2138366T3 ES96926519T ES96926519T ES2138366T3 ES 2138366 T3 ES2138366 T3 ES 2138366T3 ES 96926519 T ES96926519 T ES 96926519T ES 96926519 T ES96926519 T ES 96926519T ES 2138366 T3 ES2138366 T3 ES 2138366T3
Authority
ES
Spain
Prior art keywords
carbamates
indol
compound
leucotrene
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96926519T
Other languages
English (en)
Inventor
Matthew F Brown
Anthony Marfat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Pfizer Inc
Original Assignee
PFIZER
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER, Pfizer Inc filed Critical PFIZER
Application granted granted Critical
Publication of ES2138366T3 publication Critical patent/ES2138366T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN COMPUESTO DE FORMULA (I) DONDE R 1 Y R 2 SON SEGUN SE DEFINE, ES UTIL EN EL TRATAMIENTO DE ASMA, ARTRITIS REUMATOIDE, OSTEOARTRITIS, BRONQUITIS, OBSTRUCCIONES CRONICAS DE LAS VIAS AEREAS, PSORIASIS, RINITIS ALERGICA, DERMATITIS ATOPICA, SHOCK, Y OTRAS ENFERMEDADES INFLAMATORIAS. TAMBIEN SE DESCRIBEN COMPOSICIONES FARMACEUTICAS QUE CONTIENEN EL COMPUESTO Y METODOS DE BLOQUEO DEL RECEPTOR LEUCOTRIENO D4 CON EL COMPUESTO.
ES96926519T 1995-10-10 1996-08-26 Indol carbamatos como antagonistas de leucotrienos. Expired - Lifetime ES2138366T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US500395P 1995-10-10 1995-10-10

Publications (1)

Publication Number Publication Date
ES2138366T3 true ES2138366T3 (es) 2000-01-01

Family

ID=21713630

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96926519T Expired - Lifetime ES2138366T3 (es) 1995-10-10 1996-08-26 Indol carbamatos como antagonistas de leucotrienos.

Country Status (10)

Country Link
US (1) US5965745A (es)
EP (1) EP0863873B1 (es)
JP (1) JP3020612B2 (es)
AT (1) ATE186528T1 (es)
CA (1) CA2234239C (es)
DE (1) DE69605128T2 (es)
DK (1) DK0863873T3 (es)
ES (1) ES2138366T3 (es)
GR (1) GR3032272T3 (es)
WO (1) WO1997013751A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5982736A (en) 1997-05-15 1999-11-09 Pierson; Gerald A. Trading card optical compact disc and methods of using and forming same
PL343007A1 (en) * 1998-02-25 2001-07-30 Genetics Inst Inhibitors of phospholipase enzymes
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
JP5024039B2 (ja) 2005-02-25 2012-09-12 小野薬品工業株式会社 インドール化合物およびその用途
RU2472509C2 (ru) * 2007-11-16 2013-01-20 Эбботт Лэборетриз Способ лечения артрита
TWI469965B (zh) 2008-12-22 2015-01-21 Ono Pharmaceutical Co 乙炔基吲哚化合物
ES2572804T3 (es) 2010-06-21 2016-06-02 Ono Pharmaceutical Co., Ltd. Nuevas formas cristalinas de ácido 4,4'-[4-fluoro-7-({4-[4-(3-fluoro-2-metilfenil)butoxi]fenil}etinil)2-metil-1H-indol-1,3-diil]butanoico

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2072125T3 (es) * 1991-10-25 1995-07-01 Ciba Geigy Ag Procedimiento para la obtencion de indoles substituidos.
US5280039A (en) * 1992-11-04 1994-01-18 Pfizer Inc. Bicyclic carbamates and methods of treating inflammatory diseases using the same

Also Published As

Publication number Publication date
JPH10512291A (ja) 1998-11-24
WO1997013751A1 (en) 1997-04-17
JP3020612B2 (ja) 2000-03-15
CA2234239A1 (en) 1997-04-17
GR3032272T3 (en) 2000-04-27
EP0863873B1 (en) 1999-11-10
ATE186528T1 (de) 1999-11-15
DE69605128T2 (de) 2000-03-02
US5965745A (en) 1999-10-12
DK0863873T3 (da) 2000-05-08
EP0863873A1 (en) 1998-09-16
CA2234239C (en) 2003-05-20
DE69605128D1 (de) 1999-12-16

Similar Documents

Publication Publication Date Title
ES2154683T3 (es) Indoles sustituidos como inhibidores de fosfodiesterasa de tipo iv.
ES2162061T3 (es) Derivados de piperidina como antagonistas de la neuroquinina.
ES2184794T3 (es) Profarmacos de morfolina como antagonistas de receptores de taquicininas.
MX9405132A (es) Tetrahidro pirazolopiridinas biciclicas.
LV12568A (en) Morpholine and thiomorpholine tachykinin receptor antagonists
MX9203018A (es) Fluoroalcoxibencilamino-derivados de heterociclos nitrogenados.
NO942765D0 (no) Anvendelse av substituerte adenin derivater for behandling av multiple sclerose
ES2139754T3 (es) 3-fenil-2-isoxazolinas como agentes antiinflamatorios.
DE69630214D1 (de) Benzamidin-derivate, deren herstellung und deren verwendung als anti-koagulantien
CO4180606A1 (es) Compuestos de isoxazolina como agentes antiinflamatorios
ES2122042T3 (es) Tratamiento de rinitis alergica y asma que emplea (-)cetirizina.
EA199900787A1 (ru) Производные никотинамида
ES2158345T3 (es) Derivados de piperazino como antagonistas de la neuroquinina.
ATE249214T1 (de) Pentafluorobenzensulfonamide und analoge
MX9504422A (es) Tetrahidropirazolopiridinas biciclicas.
MX9100917A (es) Composicion farmaceutica que comprende compuestos de difenilo
ATE251614T1 (de) Piperazinderivate als neurokinin-antagonisten
NO975028D0 (no) Piperazinoderivater som neurokininantagonister
ES2161211T3 (es) Broncodilatadores antimuscarinicos.
ES2165859T3 (es) Derivados de benzoxazol y su uso como antagonistas del receptor serotonina 5ht3.
MX9300250A (es) Metodo para emplear piridobenzodiazepinonas antimuscarinicas m1-selectivas en terapia de miopia axial.
DK0863873T3 (da) Indolcarbamater som leukotrienantagonister
ES2162686T3 (es) Nuevos derivados carboxamidas ciclicos sustituidos por carboxi.
ES2119378T3 (es) Carbamatos biciclicos como antagonistas del leucotrieno d4.
AR003129A1 (es) Derivados de bencimidazol 2-sustituidos y composiciones farmaceuticas que los comprenden

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 863873

Country of ref document: ES